Ventyx Biosciences Inc (VTYX) — Financial Flexibility Index
Ventyx Biosciences Inc (VTYX) has a Financial Flexibility Index of -0.87x as of September 2025. Free cash flow of $-17.46 Million (operating CF $-17.51 Million minus capex $50.00K) represents -1% of total liabilities ($20.10 Million). Also explore VTYX net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ventyx Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Ventyx Biosciences Inc across 6 annual periods. Check VTYX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ventyx Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Ventyx Biosciences Inc. For the full company profile including market capitalisation, see Ventyx Biosciences Inc (VTYX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.80x | $-130.63 Million | $-130.87 Million | $22.52 Million | ▼ -18.0% |
| 2023 | -4.92x | $-166.01 Million | $-166.52 Million | $33.77 Million | ▲ +12.6% |
| 2022 | -5.63x | $-98.50 Million | $-98.77 Million | $17.50 Million | ▼ -80.0% |
| 2021 | -3.13x | $-38.39 Million | $-38.65 Million | $12.28 Million | ▼ -1527.7% |
| 2020 | -0.19x | $-5.93 Million | $-6.20 Million | $30.90 Million | ▲ +63.9% |
| 2019 | -0.53x | $-2.38 Million | $-2.64 Million | $4.48 Million | — |